Osteonecrosis in sickle cell disease patients from Bahia, Brazil: a cross-sectional study

  • Gildasio Daltro
  • Bruno Adelmo Franco
  • Thiago Batista Faleiro
  • Davi Araujo Veiga Rosário
  • Paula Braga Daltro
  • Vitor Fortuna
Original Paper
  • 37 Downloads

Abstract

Purpose

The aim of this study was to describe the clinical features of osteonecrosis (ON) in sickle cell disease (SCD) patients in Bahia, a Northeast state with the highest prevalence of the disease in Brazil.

Methods

Between 2006 and 2017, 283 cases of osteonecrosis in SCD patients were enrolled to analyse the age at diagnosis, genotype, gender, pain, distribution of the lesions and disease staging. MRI and radiograph were obtained at the participation.

Results

Of the 283 SCD cases, 120 (42.4%) were haemoglobin SS genotype while 163 (57.6%) were SC genotype. Two hundred and forty-six cases were bilateral and 37 were unilateral, with an average age at diagnosis of 33.7 (range 10–67) years. The most frequent identified ON site not only was the hip (74.6%), but also affected shoulder, knee and ankle. Most cases presented at early stage I (172, 60.8%) disease. No significant differences on the features of osteonecrosis were identified between haemoglobin SS and haemoglobin SC cases.

Conclusions

Given the relatively high prevalence of bilateral osteonecrosis at early stages, painful symptoms and rather late age at diagnosis, SCD patients should have radiological examination of their joints more often in order to prevent severe functional disability and increase patient’s life quality.

Keywords

Bone necrosis Sickle cell disease Femoral head Joint MRI diagnosis 

Abbreviations

HbS

haemoglobin S

MRI

magnetic resonance imaging

ON

osteonecrosis

SCD

sickle cell disease

Notes

Authors’ contributions

GD, TBF and DAR were the surgeons who performed surgeries in this study. TBF, BAM and DAR assessed most of the clinical outcomes. GD and VF were responsible for conception, design, critical revision and analysis of the results. PBD assisted data collection. BAF drafted part of the manuscript. VF coordinated and made a major contribution to writing the manuscript. All authors read and approved the final manuscript.

Compliance with ethical standards

The Committee of Ethics in Research of the Climério de Oliveira Maternity Hospital (Federal University of Bahia, UFBA) approved this study, and informed consent was obtained in accordance with ethical principles and the Helsinki Declaration of 1975, and by the Brazilian resolution 196/96, of the Ministry of Health, Law 6638/79 and Normative Resolution 04/97.

Competing interests

The authors declare that they have no competing interests.

References

  1. 1.
    Aguilar C, Vichinsky E, Neumayr L (2005) Bone and joint disease in sickle cell disease. Hematol Oncol Clin North Am 19:929–941.  https://doi.org/10.1016/j.hoc.2005.07.001 CrossRefPubMedGoogle Scholar
  2. 2.
    Adorno EV, Couto FD, Moura Neto JP, Menezes JF, Rego M, Reis MG et al (2005) Hemoglobinopathies in newborns from Salvador, Bahia, Northeast Brazil. Cad Saude Publica 21:292–298CrossRefPubMedGoogle Scholar
  3. 3.
    Brasil, Ministério da Saúde, Secretaria de Atenção à Saúde (2012) Doença Falciforme: condutas básicas para o tratamento. Brasília: Ministério da Saúde. http://bvsms.saude.gov.br/bvs/publicacoes/doenca_falciforme_condutas_basicas.pdf. Accessed 28 February 2018
  4. 4.
    Hernigou P, Habibi A, Bachir D, Galacteros F (2006) The natural history of asymptomatic osteonecrosis of the femoral head in adults with sickle cell disease. J Bone Joint Surg Am 88:2565–2572.  https://doi.org/10.2106/JBJS.E.01455 CrossRefPubMedGoogle Scholar
  5. 5.
    Flouzat-Lachaniete CH, Roussignol X, Poignard A, Mukasa MM, Manicom O, Hernigou P (2009) Multifocal joint osteonecrosis in sickle cell disease. Open Orthop J 3:32–35.  https://doi.org/10.2174/1874325000903010032 CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Hernigou P, Flouzat-Lachaniete CH, Daltro G, Galacteros F (2016) Talar osteonecrosis related to adult sickle cell disease: natural evolution from early to late stage. J Bone Joint Surg Am 98:1113–1121.  https://doi.org/10.2106/JBJS.15.01074 CrossRefPubMedGoogle Scholar
  7. 7.
    Perfetti DC, Boylan MR, Naziri Q, Khanuja HS, Urban WP (2015) Does sickle cell disease increase risk of adverse outcomes following total hip and knee arthroplasty? A nationwide database study. J Arthroplast 30:547–551.  https://doi.org/10.1016/j.arth.2014.10.035 CrossRefGoogle Scholar
  8. 8.
    Hernigou P, Daltro G (2014) Osteonecrosis in sickle-cell disease. In: Koo K, Mont MA, Jones LC (eds) Osteonecrosis. Springer-Verlag, Berlin Heidelberg, pp 125–131.  https://doi.org/10.1007/978-3-642-35767-1_16 Google Scholar
  9. 9.
    Milner PF, Kraus AP, Sebes JI, Sleeper LA, Dukes KA, Embury SH et al (1991) Sickle cell disease as a cause of osteonecrosis of the femoral head. N Engl J Med 325:1476–1481.  https://doi.org/10.1056/NEJM199111213252104 CrossRefPubMedGoogle Scholar
  10. 10.
    Marouf R, Gupta R, Haider MZ et al (2003) Avascular necrosis of the femoral head in adult Kuwaiti sickle cell disease patients. Acta Haematol 110:11–15.  https://doi.org/10.1159/000072406 CrossRefPubMedGoogle Scholar
  11. 11.
    Mahadeo KM, Oyeku S, Taragin B, Rajpathak SN, Moody K, Santizo R, Driscoll MC (2011) Increased prevalence of osteonecrosis of the femoral head in children and adolescents with sickle-cell disease. Am J Hematol 86:806–808.  https://doi.org/10.1002/ajh.22103 CrossRefPubMedGoogle Scholar
  12. 12.
    Ficat RP (1985) Idiopathic bone necrosis of the femoral head. Early diagnosis and treatment. J Bone Joint Surg Br 67:3–9CrossRefPubMedGoogle Scholar
  13. 13.
    Mont MA, Tomek IM, Hungerford DS (1997) Core decompression for avascular necrosis of the distal femur: long term follow-up. Clin Orthop Relat Res 334:124-130Google Scholar
  14. 14.
    Cruess RL (1976) Steroid-induced avascular necrosis of the head of the humerus. Natural history and management. J Bone Joint Surg Br 58:313–317CrossRefPubMedGoogle Scholar
  15. 15.
    Steinberg ME, Hayken GD, Steinberg DR (1995) A quantitative system for staging avascular necrosis. J Bone Joint Surg Br 77:34–41CrossRefPubMedGoogle Scholar
  16. 16.
    Adesina O, Brunson A, Keegan THM, Wun T (2017) Osteonecrosis of the femoral head in sickle cell disease: prevalence, comorbidities and surgical outcomes in California. Blood Adv 1:1287–1295.  https://doi.org/10.1182/bloodadvances.2017005256 CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Adekile AD, Gupta R, Yacoub F et al (2001) Avascular necrosis of the hip in children with sickle cell disease and high Hb F: magnetic resonance imaging findings and influence of a-thalassemia trait. Acta Haematol 105:27–31.  https://doi.org/10.1159/000046529 CrossRefPubMedGoogle Scholar
  18. 18.
    Balogun RA, Obalum DC, Giwa SO, Adekoya-Cole TO et al (2010) Spectrum of musculo-skeletal disorders in sickle cell disease in Lagos, Nigeria. J Orthop Surg Res 5:2.  https://doi.org/10.1186/1749-799X-5-2 CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Sun W, Shi Z, Gao F, Wang B, Li Z (2016) The pathogenesis of multifocal osteonecrosis. Sci Rep 6:29576–29582.  https://doi.org/10.1038/srep29576 CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    LaPorte DM, Mont MA, Mohan V, Jones LC, Hungerford DS (1998) Multifocal osteonecrosis. J Rheumatol 25:1968–1974PubMedGoogle Scholar
  21. 21.
    Aleluia MM, Fonseca TCC, Souza RQ, Neves FI, da Guarda CC et al (2017) Comparative study of sickle cell anemia and hemoglobin SC disease: clinical characterization, laboratory biomarkers and genetic profiles. BMC Hematol 17:15.  https://doi.org/10.1186/s12878-017-0087-7 CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Naessens V, Ward R, Kuo KHM (2017) A proposed treatment algorithm for adults with haemoglobin SC disease. Br J Haematol.  https://doi.org/10.1111/bjh.14852
  23. 23.
    Mukisi-Mukaza M, Elbaz A, Samuel-Leborgne Y, Kéclard L, Le Turdu-Chicot C, Christophe-Duchange E, Mérault G (2000) Prevalence, clinical features, and risk factors of osteonecrosis of the femoral head among adults with sickle cell disease. Orthopedics 23:357–363PubMedGoogle Scholar
  24. 24.
    Baldwin C, Nolan VG, Wyszynski DF, Ma QL et al (2005) Association of klotho, bone morphogenic protein 6, and annexin A2 polymorphisms with sickle cell osteonecrosis. Blood 106:372–375.  https://doi.org/10.1182/blood-2005-02-0548 CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Kato GJ, Steinberg MH, Gladwin MT (2017) Intravascular hemolysis and the pathophysiology of sickle cell disease. J Clin Invest 127:750–760.  https://doi.org/10.1172/JCI89741 CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Hauzeur JP, Malaise M, de Maertelaer V (2016) A prospective cohort study of the clinical presentation of non-traumatic osteonecrosis of the femoral head: spine and knee symptoms as clinical presentation of hip osteonecrosis. Int Orthop 40(7):1347–1351.  https://doi.org/10.1007/s00264-015-3079-x CrossRefPubMedGoogle Scholar

Copyright information

© SICOT aisbl 2018

Authors and Affiliations

  • Gildasio Daltro
    • 1
  • Bruno Adelmo Franco
    • 1
  • Thiago Batista Faleiro
    • 1
  • Davi Araujo Veiga Rosário
    • 1
  • Paula Braga Daltro
    • 2
  • Vitor Fortuna
    • 2
  1. 1.Prof. Edgar Santos Hospital ComplexFederal University of BahiaSalvadorBrazil
  2. 2.Health Science InstituteFederal University of BahiaSalvadorBrazil

Personalised recommendations